Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events

Subedi S, Gong Y, Chen Y, Shi Y

Drug Design, Development and Therapy 2019, 13:2491-2502

Published Date: 23 July 2019